Arix Bioscience Share Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Arix Bioscience stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ARIX, but not buy additional shares or sell existing shares.
View analyst ratings for Arix Bioscience or view top-rated stocks.

Wall Street analysts have given Arix Bioscience a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Arix Bioscience wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Arix Bioscience's stock was trading at GBX 77 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ARIX shares have increased by 128.6% and is now trading at GBX 176.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Arix Bioscience include Brooklyn ImmunoTherapeutics (BTX), Biotest Aktiengesellschaft (BIO), Ergomed (ERGO), Silence Therapeutics (SLN), Inventiva (IVA), Pfenex (PFNX), Theratechnologies (TH), Nuvo Pharmaceuticals Inc. (NRI.TO) (NRI), Burcon NutraScience (BU), Aptose Biosciences (APS), Synairgen (SNG), BELLUS Health (BLU), ProMetic Life Sciences (PLI), Neptune Wellness Solutions (NEPT) and Emblem (EMC).
View all of ARIX's competitors.

Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX."

Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of ARIX stock can currently be purchased for approximately GBX 176.

Arix Bioscience has a market capitalization of £232.28 million and generates £135.77 million in revenue each year.

Arix Bioscience employs 12 workers across the globe.

The official website for Arix Bioscience is arixbioscience.com.

Arix Bioscience is headquartered at 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom.

Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050.